Recombinant Proteins for Industrial versus Pharmaceutical Purposes: A Review of Process and Pricing

Medical Marketing in the United States, 1997-2016

(2019) Lisa M. Schwartz et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Cost-effective production of recombinant peptides in Escherichia coli

(2019) Rosa Gaglione et al.   New Biotechnology

Engineering strategies for enhanced production of protein and bio-products in Pichia pastoris : A review

(2018) Zhiliang Yang et al.   BIOTECHNOLOGY ADVANCES

Techno-economic analysis of the industrial production of a low-cost enzyme using E. coli: the case of recombinant β-glucosidase

(2018) Rafael da Gama Ferreira et al.   Biotechnology for Biofuels

Archaeobotanical evidence reveals the origins of bread 14,400 years ago in northeastern Jordan

(2018) Amaia Arranz-Otaegui et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Estimated Costs of Pivotal Trials for Novel Therapeutic Agents Approved by the US Food and Drug Administration, 2015-2016

(2018) Thomas J. Moore et al.   JAMA Internal Medicine

Research and Development Spending to Bring a Single Cancer Drug to Market and Revenues After Approval

(2017) Vinay Prasad et al.   JAMA Internal Medicine

Innovation in the pharmaceutical industry: New estimates of R&D costs

(2016) Joseph A. DiMasi et al.   JOURNAL OF HEALTH ECONOMICS

Microbial enzymes: industrial progress in 21st century

(2016) Rajendra Singh et al.   3 Biotech

Microbial enzymes: industrial progress in 21st century

(2016) Rajendra Singh et al.   3 Biotech

Cost evaluation of cellulase enzyme for industrial-scale cellulosic ethanol production based on rigorous Aspen Plus modeling

(2015) Gang Liu et al.   BIOPROCESS AND BIOSYSTEMS ENGINEERING

Advances in protease engineering for laundry detergents

(2015) Ljubica Vojcic et al.   New Biotechnology

Analytical Quality by Design: A Tool for Regulatory Flexibility and Robust Analytics

(2015) Ramalingam Peraman et al.   International Journal of Analytical Chemistry

Preparative Purification of Recombinant Proteins: Current Status and Future Trends

(2013) Mayank Saraswat et al.   Biomed Research International

Production of recombinant immunotherapeutics for anticancer treatment

(2013) Maria-Cristina S Pranchevicius et al.   Bioengineered

Safety and prolonged activity of recombinant factor VIII Fc fusion protein in hemophilia A patients

(2012) J. S. Powell et al.   BLOOD

Manufacturing recombinant proteins in kg-ton quantities using animal cells in bioreactors

(2011) Maria De Jesus et al.   EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS

The cost of drug development: A systematic review

(2011) Steve Morgan et al.   HEALTH POLICY

Production of recombinant proteins by microbes and higher organisms

(2009) Arnold L. Demain et al.   BIOTECHNOLOGY ADVANCES

Development and Production of Commercial Therapeutic Monoclonal Antibodies in Mammalian Cell Expression Systems: An Overview of the Current Upstream Technologies

(2008) Michel Chartrain et al.   CURRENT PHARMACEUTICAL BIOTECHNOLOGY

The Cost of Pushing Pills: A New Estimate of Pharmaceutical Promotion Expenditures in the United States

(2007) Marc-André Gagnon et al.   PLOS MEDICINE